Overexpression of CD44 accompanies acquired tamoxifen resistance in MCF7 cells and augments their sensitivity to the stromal factors, heregulin and hyaluronan.
about
Hyaluronan, Inflammation, and Breast Cancer ProgressionCCNA2 is a prognostic biomarker for ER+ breast cancer and tamoxifen resistanceExtracellular molecules involved in cancer cell invasionTransforming growth factor-β1 induces EMT by the transactivation of epidermal growth factor signaling through HA/CD44 in lung and breast cancer cellsActivated ERK1/2 increases CD44 in glomerular parietal epithelial cells leading to matrix expansion.Predictive value of CD44 and CD24 for prognosis and chemotherapy response in invasive breast ductal carcinomaCrosstalk between PKCα and Notch-4 in endocrine-resistant breast cancer cells.MtDNA depletion influences the transition of CD44 subtypes in human prostate cancer DU145 cells.Overexpression of Specific CD44 Isoforms Is Associated with Aggressive Cell Features in Acquired Endocrine Resistance.Both bulk and cancer stem cell subpopulations in triple-negative breast cancer are susceptible to Wnt, HDAC, and ERα coinhibition.Breast Cancer Cell Line Classification and Its Relevance with Breast Tumor Subtyping.Receptor tyrosine kinases (RTKs) in breast cancer: signaling, therapeutic implications and challenges.Indocyanine green-incorporating nanoparticles for cancer theranostics.Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1.Isobavachalcone sensitizes cells to E2-induced paclitaxel resistance by down-regulating CD44 expression in ER+ breast cancer cells
P2860
Q27006607-F8579ADB-3525-490E-8989-58453A2EA845Q28540790-E2DCD244-81F1-41CC-A2F4-E787E0C61A65Q35237503-D6E470A5-1580-4B48-8D23-ED58DC01E6A3Q35827597-A0E3C11C-E748-4112-AC2A-4A66923B430DQ36229809-92746A1D-5320-4299-947C-EE2245D3A7E0Q36261757-371B5731-C82C-4EB6-B836-A9004C2B6B10Q37137262-9DE7D842-7A3A-4916-ADA2-87C1BEC4EB35Q38695440-C3E9E3C2-B264-4E8C-925C-888FF728B7C3Q38845190-F9BF7FD3-0D0B-4074-91A6-D6F8372F9932Q45416563-757BA981-8829-43C1-B0CE-F386EFDBDECFQ47100468-A9AB3CD0-BFC9-4A1E-822D-546308024104Q49887925-8E79BD5A-E838-4260-873B-777F78077756Q52673018-53E44A99-2B88-4671-A886-08717A04E1ADQ53692325-ACD0E5C3-8C69-423A-9516-1918BC3E0A8DQ58764017-F1AFC652-BB0D-43AD-80A3-63290036165A
P2860
Overexpression of CD44 accompanies acquired tamoxifen resistance in MCF7 cells and augments their sensitivity to the stromal factors, heregulin and hyaluronan.
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Overexpression of CD44 accompa ...... ors, heregulin and hyaluronan.
@ast
Overexpression of CD44 accompa ...... ors, heregulin and hyaluronan.
@en
Overexpression of CD44 accompa ...... ors, heregulin and hyaluronan.
@nl
type
label
Overexpression of CD44 accompa ...... ors, heregulin and hyaluronan.
@ast
Overexpression of CD44 accompa ...... ors, heregulin and hyaluronan.
@en
Overexpression of CD44 accompa ...... ors, heregulin and hyaluronan.
@nl
prefLabel
Overexpression of CD44 accompa ...... ors, heregulin and hyaluronan.
@ast
Overexpression of CD44 accompa ...... ors, heregulin and hyaluronan.
@en
Overexpression of CD44 accompa ...... ors, heregulin and hyaluronan.
@nl
P2093
P2860
P50
P356
P1433
P1476
Overexpression of CD44 accompa ...... tors, heregulin and hyaluronan
@en
P2093
Bedanta Baruha
Chris Smith
Lindy Goddard
Nicola Jordan
Rebecca Bellerby
Robert I Nicholson
Zaruhi Poghosyan
P2860
P2888
P356
10.1186/1471-2407-12-458
P407
P577
2012-10-06T00:00:00Z
P5875
P6179
1015205270